1
|
Diviani D, Dodge-Kafka KL, Li J and
Kapiloff MS: A-kinase anchoring proteins: scaffolding proteins in
the heart. Am J Physiol Heart Circ Physiol. 301:H1742–H1753. 2011.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Arsenijevic T, Degraef C, Dumont JE, Roger
PP and Pirson I: A novel partner for D-type cyclins: protein kinase
A-anchoring protein AKAP95. Biochem J. 378:673–679. 2004.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Arsenijevic T, Degraef C, Dumont JE, Roger
PP and Pirson I: G1/S Cyclins interact with regulatory subunit of
PKA via A-kinase anchoring protein, AKAP95. Cell Cycle.
5:1217–1222. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Møller MB, Nielsen O and Pedersen NT:
Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with
other cell cycle regulators and clinical features. Am J Clin
Pathol. 115:404–412. 2001. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bukholm IR, Bukholm G and Nesland JM:
Over-expression of cyclin A is highly associated with early relapse
and reduced survival in patients with primary breast carcinomas.
Int J Cancer. 93:283–287. 2001. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Fatrai S, Elghazi L, Balcazar N, et al:
Akt induces beta-cell proliferation by regulating cyclin D1, cyclin
D2 and p21 levels and cyclin-dependent kinase-4 activity. Diabetes.
55:318–325. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hiscott PS, Grierson I and McLeod D:
Retinal pigment epithelial cells in epiretinal membranes: an
immunohistochemical study. Br J Ophthalmol. 68:708–715. 1984.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Collas P, Le Guellec K and Taskén K: The
A-kinase-anchoring protein AKAP95 is a multivalent protein with a
key role in chromatin condensation at mitosis. J Cell Biol.
147:1167–1180. 1999. View Article : Google Scholar : PubMed/NCBI
|
9
|
Steen RL, Cubizolles F, Le Guellec K and
Collas P: A kinase-anchoring protein (AKAP)95 recruits human
chromosome-associated protein (hCAP)-D2/Eg7 for chromosome
condensation in mitotic extract. J Cell Biol. 149:531–536. 2000.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Eide T, Carlson C, Taskén KA, Hirano T,
Taskén K and Collas P: Distinct but overlapping domains of AKAP95
are implicated in chromosome condensation and condensin targeting.
EMBO Rep. 3:426–432. 2002. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kamada S, Kikkawa U, Tsujimoto Y and
Hunter T: A-kinase-anchoring protein 95 functions as a potential
carrier for the nuclear translocation of active caspase 3 through
an enzyme-substrate-like association. Mol Cell Biol. 25:9469–9477.
2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mayadagli A, Karabulut Gul S, Bilici A, et
al: Prognostic significance of protein kinase B/Akt pathway in
patients with non-small cell lung cancer. J BUON. 19:157–163.
2014.PubMed/NCBI
|
13
|
Dominguez-Sola D and Dalla-Favera R:
Burkitt lymphoma: much more than MYC. Cancer Cell. 22:141–142.
2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Flørenes VA, Faye RS, Maelandsmo GM,
Nesland JM and Holm R: Levels of cyclin D1 and D3 in malignant
melanoma: deregulated cyclin D3 expression is associated with poor
clinical outcome in superficial melanoma. Clin Cancer Res.
6:3614–3620. 2000.PubMed/NCBI
|
15
|
Wolowiec D, Ciszak L, Kosmaczewska A, et
al: Cell cycle regulatory proteins and apoptosis in B-cell chronic
lymphocytic leukemia. Haematologica. 86:1296–1304. 2001.PubMed/NCBI
|
16
|
Papay J, Krenacs T, Moldvay J, et al:
Immunophenotypic profiling of nonsmall cell lung cancer progression
using the tissue microarray approach. Appl Immunohistochem Mol
Morphol. 15:19–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Hu SX, Kong XY, Yuan YY, et al:
Relationship between AKAP95, cyclin E1, cyclin D1 and
clinicopathological parameters in lung cancer tissue. Zhonghua Lao
Dong Wei Sheng Zhi Ye Bing Za Zhi. 31:890–894. 2013.PubMed/NCBI
|
18
|
Yu J, Miehlke S, Ebert MP, et al:
Expression of cyclin genes in human gastric cancer and in first
degree relatives. Chin Med J (Engl). 115:710–715. 2002.PubMed/NCBI
|
19
|
David O, Jett J, LeBeau H, et al:
Phospho-Akt overexpression in non-small cell lung cancer confers
significant stage-independent survival disadvantage. Clin Cancer
Res. 10:6865–6871. 2004. View Article : Google Scholar : PubMed/NCBI
|
20
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|